CLASS II Device recall · Reported 18 Jul 2018 · FDA Enforcement Report
PD-L1 IHC 22C3 pharmDx is a companion diagnostic used recalled
Dako North America is recalling PD-L1 IHC 22C3 pharmDx is a companion diagnostic used to determine PD-L1 levels for, distributed in 29 states. The recall was initiated on 2 Feb 2018 and the FDA has classified it as Class II.
Check your package
Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.
Recall details
- Recall number
- Z-2425-2018
- FDA event ID
- 79602
- Recalling firm
- Dako North America, Carpinteria, CA
- Classification
- Class II
- Status
- Terminated
- Recall initiated
- 2 Feb 2018
- FDA classified
- 11 Jul 2018
- Reported
- 18 Jul 2018
- Type
- Voluntary: Firm initiated
- Customers notified by
- Letter
- Reason category
- Other Reasons
- Device type
- Test Kits & Diagnostics
Timeline
| 2 Feb 2018 | Recall initiated by company | |
| 11 Jul 2018 | Classified by FDA | +159 days |
| 18 Jul 2018 | Published in enforcement report | +7 days |
Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.
Reason for recall
To correct the kit's instructions for use as the storage time for gastric and gastroesophageal junction adenocarcinoma cut sections will be changed from six months to five months.
Product as listed by the FDA
PD-L1 IHC 22C3 pharmDx is a companion diagnostic used to determine PD-L1 levels for determination of patient treatment options.
Where it was distributed
AZ, CA, CO, CT, DC, FL, GA, IL, IN, KS, KY, LA, MA, MD, ME, MI, MO, NH, NJ, NV, NY, OH, OK, PA, TX, UT, VA, WA, and WI
ArizonaCaliforniaColoradoConnecticutDistrict of ColumbiaFloridaGeorgiaIllinoisIndianaKansasKentuckyLouisianaMassachusettsMarylandMaineMichiganMissouriNew HampshireNew JerseyNevada
Questions about this recall
Why was it recalled?
To correct the kit's instructions for use as the storage time for gastric and gastroesophageal junction adenocarcinoma cut sections will be changed from six months to five months.
Which lots are affected?
Code No SK006 Lot #'s: 10127731A, 10126716C, 10127741, 10129051 and 10132199
Where was it sold?
AZ, CA, CO, CT, DC, FL, GA, IL, IN, KS, KY, LA, MA, MD, ME, MI, MO, NH, NJ, NV, NY, OH, OK, PA, TX, UT, VA, WA, and WI
What should I do if I have it?
Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.
What does Class II mean?
Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.
Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.
More recalls from Dako North America
All 8| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Device | CLASS II | Dako HER2 CISH pharmDx Kit, product recalled by Dako North America | Dako North America | Other | Nationwide |
| Device | CLASS II | EnVision Flex/Hrp visualization reagent found recalled | Dako North America | Device Malfunction | Nationwide |
| Device | CLASS II | Test Request Distributor (TRD 1.3 and TRD 1.4) recalled | Dako North America | Device Malfunction | Nationwide |
| Device | CLASS II | Autostainer Plus Link Instrument (AS100) recalled by Dako North America | Dako North America | Packaging Defects | Nationwide |
| Device | CLASS II | Dako Autostainer Link recalled by Dako North America | Dako North America | Device Malfunction | Nationwide |
Other Test Kits & Diagnostics recalls
All 2,656| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Device | CLASS II | STA Staclot Protein recalled by Diagnostica Stago | Diagnostica Stago | Potency & Assay | Nationwide |
| Device | CLASS II | DxC 500i Clinical Analyzer Modules using recalled by Beckman Coulter | Beckman Coulter | Packaging Defects | Nationwide |
| Device | CLASS II | DxC 500 AU Clinical Analyzer Modules using recalled by Beckman Coulter | Beckman Coulter | Packaging Defects | Nationwide |
| Device | CLASS II | Syva EMIT 2000 Quinidine Assay recalled | Siemens Healthcare Diagnostics | Potency & Assay | Nationwide |
| Device | CLASS II | Beckman Coulter, Emit 2000 Quinidine Assay recalled | Siemens Healthcare Diagnostics | Potency & Assay | Nationwide |